Form 4: BEL FUSE Director Rita Smith Granted Restricted Stock
Insider Transaction Report
BEL FUSE Inc. Director Rita Smith was granted 1,030 restricted shares of Class B Common Stock, vesting over three years.
Summary
- Rita Smith, a Director of BEL FUSE INC /NJ (BELFB), acquired 1,030 shares of Class B Common Stock.
- The transaction occurred on March 15, 2026, and was a grant of restricted shares with a price of $0 per share.
- Following this transaction, Dr. Smith beneficially owns a total of 5,827 shares of Class B Common Stock.
- The 1,030 restricted shares vest in three annual installments: 343 shares on March 15, 2027; 343 shares on March 15, 2028; and 344 shares on March 15, 2029.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive event. It represents routine director compensation and aligns the director's interests with shareholders, without indicating any significant operational or financial changes.
Positives
- The grant of restricted shares to a director aligns management's interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
Future Outlook
The restricted shares granted to Director Rita Smith are scheduled to vest in three annual installments on March 15, 2027, March 15, 2028, and March 15, 2029, indicating a future commitment and retention mechanism for the director.
Industry Context
StockSavvy.ai notes that the grant of restricted stock to directors is a standard practice in corporate governance, commonly used to compensate board members and align their long-term interests with those of the company's shareholders. This type of equity compensation is prevalent across various industries, including manufacturing and electronics components, where BEL FUSE operates.
Related Party Transactions
- The grant of restricted shares to Director Rita Smith by BEL FUSE Inc. constitutes a related party transaction, as it involves compensation from the company to a member of its board of directors.
Stakeholder Impact
- Shareholders: The grant of restricted stock aims to align the director's long-term interests with shareholder value creation, potentially leading to more focused governance.
- Employees: No direct impact on general employees is indicated by this filing.
Next Steps
- Vesting of 343 restricted shares on March 15, 2027.
- Vesting of 343 restricted shares on March 15, 2028.
- Vesting of 344 restricted shares on March 15, 2029.
Key Dates
| Date | Description |
|---|---|
| 03/15/2026 | Date Dr. Smith was granted 1,030 restricted shares of Class B Common Stock. |
| 03/15/2027 | First vesting date for 343 restricted shares. |
| 03/15/2028 | Second vesting date for 343 restricted shares. |
| 03/15/2029 | Third and final vesting date for 344 restricted shares. |
| 03/17/2026 | Signature date of the reporting person's representative. |
Recommendation
holdThis Form 4 filing details a routine grant of restricted stock to a director as part of their compensation. It does not provide new fundamental information about the company's financial performance, strategic direction, or operational outlook that would warrant a change in an investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining the existing investment thesis.
Keywords
BEL FUSE, BELFB, Form 4, insider transaction, restricted stock, director compensation, equity grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.